WHO ICTRP trial
A study to assess the safety and tolerability of different doses of WVE-210201…
EUCTR2017-002686-21-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-002686-21-BE |
|---|---|
| Public title | A study to assess the safety and tolerability of different doses of WVE-210201 in patients with Duchenne Muscular Dystrophy |
| Scientific title | A Multicenter, Double-blind, Placebo-controlled, Phase 1 Study of WVE-210201 Administered Intravenously to Patients with Duchenne Muscular Dystrophy |
| Primary sponsor | Wave Life Sciences Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | France;United States;Canada;Belgium;Netherlands;Italy;United Kingdom |
| Conditions | Duchenne Muscular Dystrophy MedDRA version: 20.0 Level: PT Classification code 10013801 Term: Duchenne muscular dystrophy System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Nervous… |
| Interventions | Product Name: WVE-210201 Product Code: WVE-210201 Pharmaceutical Form: Solution for infusion INN or Proposed INN: WVE-210201 Current Sponsor code: WVE-210201 Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Dec 3, 2018 |
| Target size | 32 |
| Secondary IDs | WVE-DMDX51-001;2017-002686-21-GB |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: